Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.280
-0.040 (-3.03%)
Jan 28, 2026, 11:26 AM EST - Market open
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $112.99 million as of January 28, 2026. Its market cap has increased by 245.73% in one year.
Market Cap
112.99M
Enterprise Value
77.57M
1-Year Change
245.73%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $112.99M, a decrease of -55.94%. That is a compound annual growth rate of -17.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 121.82M | 2.22% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 126.68M |
| Oncolytics Biotech | 124.82M |
| Artiva Biotherapeutics | 119.04M |
| Adagene | 117.36M |
| Verrica Pharmaceuticals | 116.89M |
| MacroGenics | 116.40M |
| Repare Therapeutics | 114.24M |
| MAIA Biotechnology | 112.88M |